Insider buying last 90 days
No open-market insider purchases were filed for CTVA in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 4 close
Corteva's shares this week have been dominated by the spinoff of its seed business into a new public company, Vylor, following a U.S. separation, alongside a dividend cut. The quarterly dividend was reduced to $0.05 per share, a 72.2% reduction from the previous $0.18 payout, payable on December 15 to shareholders of record on December 1. The stock also touched a 52-week low of $11.47 during the week before closing Friday at $11.64, up 1.5% on the day.
Corteva trades at $11.64, below both its 50-day average of $34.21 and 200-day average of $68.23, with the shorter average beneath the longer one, underscoring a weak trend. The GekkoIndex reads 69.1, placing the stock in the Accumulation zone. Price sits 33.8% below Gekko Fair Value of $17.58. Over the past year the stock has moved -81.6%, with a three-month return of -84.7% and a six-month return of -85.6%.
Corteva's next earnings date is 11 November 2026, 6 days away, falling inside a typical 20-trading-day holding window; the last reaction to results was -13%, against five beats in eight quarters. In the last 90 days, Congress recorded 1 buy and 0 sells. Analyst coverage from 15 firms shows 13 buy and 2 hold ratings, with a consensus target of $17.13. Seasonally, the next 20 trading days have averaged +3.2% over 5 years, rising in 4 of them.
Written by AI from the Oct 30, 2026 close and checked automatically against the figures on this page.
Corteva scores 3 supportive, 0 mixed and 3 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed3 headwinds
Below 50 and 200-day
Close $12.26 is below the 50-day ($29.98) and 200-day ($67.36) averages, and the 50-day is below the 200-day.
See the chart69.1, Accumulation
Reading 69.1 is in the Accumulation zone.
See the GekkoIndex27.2% below
Price is 27.2% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: Congress 1 buy / 0 sales.
See smart moneyReports in 6 days
Reports on Nov 11, 2026, 6 days away — inside a typical 20-trading-day hold.
See earnings−1.7% on average
From this point in the calendar, the next 20 trading days averaged −1.7% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Corteva closed at $12.26 on Nov 4, 2026, −80.2% over the past year, inside a 52-week range of $11.25 to $90.97.
Use the left and right arrow keys to read daily values.
Put CTVA on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Corteva works in agriculture, supplying farmers with tools meant to raise yields and manage crop health. Its offerings include seed genetics and trait technologies designed to help crops withstand weather, disease, insects and herbicide use, along with improved nutritional qualities, plus digital tools that support decisions on product selection and profitability.
The business is divided into two segments. The Seed segment focuses on germplasm, traits and related digital farming support, while the Crop Protection segment supplies herbicides, insecticides, nitrogen stabilizers, pasture and range management products, and technologies applied to seeds and soil to guard against weeds, pests and disease. Its customers sit within the agricultural input trade, and it operates across the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East and Africa.
Corteva traces its founding to 1802 and is headquartered in Indianapolis, Indiana. Its shares are listed on the NYSE under the ticker CTVA.
Corteva’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 69.1, in the Accumulation zone, down 0.2 points over five sessions.
Down 0.2 points over five sessions.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days |
|---|---|---|---|
| Buying | 142 | +1.5% | +4.0% |
| Accumulation (current zone) | 313 | +0.5% | +2.2% |
| Neutral | 598 | −0.7% | −2.1% |
| Distribution | 177 | −0.1% | −1.2% |
| Selling | 12 | +1.3% | +4.8% |
Average CTVA share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Corteva trades 27.2% below Gekko Fair Value of $16.83, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Corteva shares are worth, recalculated every trading day.
$16.83
Gekko Fair Value, Nov 4, 2026
27.2% Undervalued
At the end of Aug 2026 the price was 5.9% above the estimate.
No open-market insider purchases were filed for Corteva, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for CTVA in the last 90 days.
From Form 4 filings, dated to when each was filed.
1trade disclosed: 1 purchase and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 4 |
From congressional disclosures, which report amounts as ranges.
Corteva has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds CTVA.
Corteva reports on Nov 11, 2026 (6 days away), and beat the EPS estimate in 5 of its last 8 reports.
Nov 11, 2026
6 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $2.30 est $2.24 | $6.38B est $6.60B | −13.0% |
| May 6, 2026 | $0.23 est $0.18 | $4.91B est $4.64B | −5.8% |
| Feb 4, 2026 | $0.03 est $0.03 | $3.91B est $4.24B | −3.4% |
| Nov 5, 2025 | −$0.03 est −$0.08 | $2.62B est $2.47B | +1.0% |
| Aug 6, 2025 | $2.20 est $1.89 | $6.46B est $6.27B | −1.7% |
| May 7, 2025 | $1.13 est $0.87 | $4.42B est $4.54B | +7.1% |
| Feb 5, 2025 | −$0.06 est $0.20 | $3.98B est $4.04B | −5.1% |
| Nov 6, 2024 | −$0.76 est −$0.45 | $2.33B est $2.70B | −5.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Corteva is $17.13, +39.7% from the last close, from 13 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 13 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 12 | UBS | $15 | +22.3% |
| Oct 7 | RBC Capital | $17 | +38.7% |
| Oct 7 | KeyBanc | $17 | +38.7% |
| Oct 6 | Mizuho Securities | $16 | +30.5% |
| Oct 6 | J.P. Morgan | $19 | +55.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Corteva averaged −1.7% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −2.6% | 2 of 5 |
| Next 10 trading days | −1.4% | 2 of 5 |
| Next 15 trading days | −0.1% | 2 of 5 |
| Next 20 trading days | −1.7% | 2 of 5 |
| Next 30 trading days | −3.5% | 1 of 5 |
For scale, CTVA’s typical 20-trading-day move in either direction is about 5%.
Corteva’s market cap is $8.18B, with a P/E ratio of 7.2 and revenue of $4.97B over the last twelve months.
Coverage of Corteva this week reads neutral: 1 positive, 10 neutral and 0 negative headlines.
Corteva’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| ADMArcher-Daniels-Midland | Buying | 9.3% below |
| BGBunge | Buying | 19.5% below |
| PPCPilgrim's Pride | Neutral | 33.9% below |
| SEBSeaboard | Buying | 14.6% below |
| CALMCal-Maine Foods | Neutral | 27.4% below |
| AGROAdecoagro | Accumulation | 42.7% below |
A peer links to its own page where one exists.
Corteva’s market cap is $8.18B at the Nov 4, 2026 close of $12.26, with 667.2M shares outstanding. The shares trade on a P/E ratio of 7.2.
The consensus analyst 12-month price target for Corteva is $17.13, +39.7% from the last close. Of the 13 firms that rated the stock in the last 90 days, 11 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Corteva is undervalued: the Nov 4, 2026 close of $12.26 is 27.2% below Gekko Fair Value of $16.83. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Corteva is expected to report on Nov 11, 2026 (6 days away). Analysts expect earnings of $0.02 per share on revenue of $1.77B. Corteva beat the earnings estimate in 5 of its last 8 reports, moving 5.3% on average across the report.
Corteva’s 52-week high is $90.97 and its 52-week low is $11.25; it closed at $12.26 on Nov 4, 2026, −80.2% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (gekkoindex, fair value and smart money) and 3 as headwinds (trend, earnings risk and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.